Desarrollo de tratamientos para síndromes de epilepsia: oportunidades para SYNGAP1
Medicine seminar by Ana Mingorance PhD, Dracaena Consulting / Fundación Loulou (España)
Hosted by SYNGAP by SRF
Friday 00:30–01:40 Bogota (GMT-5)
Ended
Topics
Related seminars
SeminarSeminarSeminar
Targeting alternative splicing of SYNGAP1 using antisense oligonucleotides
More on disease and epilepsy
Recording · Sep 29, 2022
Developmental origins and emerging therapeutic perspectives in genetic epilepsies
More on epilepsy and neurodevelopmental disorders
Recording · Jul 23, 2020
The use of milk exosomes to increase the expression of SYNGAP1 expression in SYNGAP1 mice
More on disease and epilepsy
Recording · Mar 3, 2022